Literature DB >> 10409685

Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase.

H Li1, C S Raman, C B Glaser, E Blasko, T A Young, J F Parkinson, M Whitlow, T L Poulos.   

Abstract

The crystal structures of the heme domain of human inducible nitric-oxide synthase (NOS-2) in zinc-free and -bound states have been solved. In the zinc-free structure, two symmetry-related cysteine residues form a disulfide bond. In the zinc-bound state, these same two cysteine residues form part of a zinc-tetrathiolate (ZnS(4)) center indistinguishable from that observed in the endothelial isoform (NOS-3). As in NOS-3, ZnS(4) plays a key role in stabilizing intersubunit contacts and in maintaining the integrity of the cofactor (tetrahydrobiopterin) binding site of NOS-2. A comparison of NOS-2 and NOS-3 structures illustrates the conservation of quaternary structure, tertiary topology, and substrate and cofactor binding sites, in addition to providing insights on isoform-specific inhibitor design. The structural comparison also reveals that pterin binding does not preferentially stabilize the dimer interface of NOS-2 over NOS-3.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409685     DOI: 10.1074/jbc.274.30.21276

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  CASTp: Computed Atlas of Surface Topography of proteins.

Authors:  T Andrew Binkowski; Shapor Naghibzadeh; Jie Liang
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Intracellular formation of "undisruptable" dimers of inducible nitric oxide synthase.

Authors:  Pawel J Kolodziejski; Mohammad B Rashid; N Tony Eissa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

3.  Insight into structural rearrangements and interdomain interactions related to electron transfer between flavin mononucleotide and heme in nitric oxide synthase: A molecular dynamics study.

Authors:  Yinghong Sheng; Linghao Zhong; Dahai Guo; Gavin Lau; Changjian Feng
Journal:  J Inorg Biochem       Date:  2015-08-07       Impact factor: 4.155

4.  Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold.

Authors:  Ha T Do; Huiying Li; Georges Chreifi; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2019-02-25       Impact factor: 7.446

5.  Dissociation and unfolding of inducible nitric oxide synthase oxygenase domain identifies structural role of tetrahydrobiopterin in modulating the heme environment.

Authors:  Rajib Sengupta; Rupam Sahoo; Sougata Sinha Ray; Tanmay Dutta; Anjan Dasgupta; Sanjay Ghosh
Journal:  Mol Cell Biochem       Date:  2006-01-13       Impact factor: 3.396

6.  Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite.

Authors:  Ming-Hui Zou; Chaomei Shi; Richard A Cohen
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

7.  Structural basis for isoform-selective inhibition in nitric oxide synthase.

Authors:  Thomas L Poulos; Huiying Li
Journal:  Acc Chem Res       Date:  2012-10-02       Impact factor: 22.384

8.  Substrate-ligand interactions in Geobacillus stearothermophilus nitric oxide synthase.

Authors:  Mariam Kabir; Jawahar Sudhamsu; Brian R Crane; Syun-Ru Yeh; Denis L Rousseau
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

9.  Conformational changes in redox pairs of protein structures.

Authors:  Samuel W Fan; Richard A George; Naomi L Haworth; Lina L Feng; Jason Y Liu; Merridee A Wouters
Journal:  Protein Sci       Date:  2009-08       Impact factor: 6.725

Review 10.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.